The complex role of ZEB1 within AML extends to its effect on the immunological landscape, where it downregulates CD8 T cell activity and promotes the expansion of Th17 cells, enhancing the survival and proliferative capabilities of leukemia cells in the AML niche. This evidence concerns the gene CD8A and acute myeloid leukemia.